|
| | Karavilagenin D Basic information |
| Product Name: | Karavilagenin D | | Synonyms: | Karavilagenin D;19-Norlanosta-6,23-diene-9-carboxylic acid, 3,5,25-trihydroxy-, γ-lactone, (3β,5β,9β,10α,23E)- | | CAS: | 934739-29-4 | | MF: | C30H46O4 | | MW: | 470.68384 | | EINECS: | | | Product Categories: | | | Mol File: | 934739-29-4.mol |  |
| | Karavilagenin D Chemical Properties |
| Boiling point | 595.8±50.0 °C(Predicted) | | density | 1.13±0.1 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 14.54±0.29(Predicted) |
| | Karavilagenin D Usage And Synthesis |
| Description | Karavilagenin D exhibits inhibitory effects on skin-tumor promotion in an in vivo two-stage mouse skin carcinogenesis test based on 7,12-dimethylbenz[a]anthracene (DMBA) as initiator, and with TPA as a promoter.
Karavilagenin D exhibits inhibition effect against human cancer cell lines. |
| | Karavilagenin D Preparation Products And Raw materials |
|
